Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Revenue
Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending March 31, 2025, Blueprint Medicines generated $149.41M in revenue.
Revenue (ttm)
508.82M
Revenue Growth
104.04%
Price / Sales Ratio
10.77
Revenue / Employee
746.08K
Employees
682
Market Cap
8.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|